- Home
- AMST vs PHIO Comparison
AMST vs PHIO Comparison
Compare AMST & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- PHIO
- Stock Information
- Founded
- AMST 2017
- PHIO 2011
- Country
- AMST United States
- PHIO United States
- Employees
- AMST N/A
- PHIO N/A
- Industry
- AMST Computer Software: Prepackaged Software
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- PHIO Health Care
- Exchange
- AMST Nasdaq
- PHIO Nasdaq
- Market Cap
- AMST 9.5M
- PHIO 8.6M
- IPO Year
- AMST 2020
- PHIO N/A
- Fundamental
- Price
- AMST $2.84
- PHIO $2.96
- Analyst Decision
- AMST
- PHIO Strong Buy
- Analyst Count
- AMST 0
- PHIO 2
- Target Price
- AMST N/A
- PHIO $9.00
- AVG Volume (30 Days)
- AMST 3.4M
- PHIO 701.6K
- Earning Date
- AMST 05-15-2025
- PHIO 05-15-2025
- Dividend Yield
- AMST N/A
- PHIO N/A
- EPS Growth
- AMST N/A
- PHIO N/A
- EPS
- AMST N/A
- PHIO N/A
- Revenue
- AMST $82,544.00
- PHIO N/A
- Revenue This Year
- AMST N/A
- PHIO N/A
- Revenue Next Year
- AMST N/A
- PHIO N/A
- P/E Ratio
- AMST N/A
- PHIO N/A
- Revenue Growth
- AMST N/A
- PHIO N/A
- 52 Week Low
- AMST $2.00
- PHIO $0.97
- 52 Week High
- AMST $6.27
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- AMST 54.10
- PHIO 77.11
- Support Level
- AMST $2.67
- PHIO $1.71
- Resistance Level
- AMST $3.04
- PHIO $2.08
- Average True Range (ATR)
- AMST 0.29
- PHIO 0.18
- MACD
- AMST -0.02
- PHIO 0.09
- Stochastic Oscillator
- AMST 21.90
- PHIO 84.46
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.